ChemistryOpen 6 , 501505 (2017)
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Liraglutide is the active ingredient in the brand-name GLP-1 medications Saxenda and Victoza, while semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus
Semaglutide combination blends Some compounded formulations combine semaglutide with other ingredients like vitamin B12 , glycine , methylcobalamin , or L-carnitine
One of the most important factors in peptide therapy is the source of the medication itself
Current FDA guidance recommends stopping semaglutide (Wegovy, Ozempic) at least two months before planned pregnancy, based on the medication's elimination half-life of approximately one week
Sources: Greenwood-Van Meerveld B, et al